KEROS THERAPEUTICS INC. - COMMON STOCK

Keros Therapeutics Announces Issuance of U.S. Patent for Use of Therapeutic Proteins in Treatment of Musculoskeletal Disorders

25 май 2021 07:00:05 Источник Nasdaq GlobeNewswire

Keros Therapeutics Presents Results from Preclinical Study of KER-012 in Pulmonary Arterial Hypertension at the American Thoracic Society International Conference

14 май 2021 07:00:00 Источник Nasdaq GlobeNewswire

Keros Therapeutics to Present at the Virtual 26th Annual Congress of the European Hematology Association

12 май 2021 15:01:00 Источник Nasdaq GlobeNewswire

Keros Therapeutics Reports Recent Business Highlights and First Quarter 2021 Financial Results

06 май 2021 15:01:02 Источник Nasdaq GlobeNewswire

Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2020 Financial Results

25 мар 2021 07:00:01 Источник Nasdaq GlobeNewswire

Keros Therapeutics Presents Results from Preclinical Studies of KER-050 and ALK2 Inhibitors at the European School of Haematology (ESH) 2nd Translational Research E-Conference

05 мар 2021 07:00:00 Источник Nasdaq GlobeNewswire

Keros Therapeutics to Present at the H.C. Wainwright Global Life Sciences 2021 Virtual Conference

02 мар 2021 07:00:02 Источник Nasdaq GlobeNewswire

Keros Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference

17 фев 2021 07:00:01 Источник Nasdaq GlobeNewswire